GlassScriptPhysician profile
Frederick R Bossert
NPI 1801139498
$1,122.78
in general payments reported to CMS, 2019-2025
10 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.32 · 2021: $389 · 2023: $112 · 2024: $305 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.47 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $404.08 | 2021-2024 | |
| Astellas Pharma US INC | $324.31 | 2024-2025 | Veozah |
| Bard Peripheral Vascular, INC. | $145.58 | 2024 | Venovo |
| Dexcom, INC. | $111.57 | 2023 | Dexcom G7 Gss (161) |
| Pfizer INC. | $39.68 | 2024-2025 | |
| Shield Therapeutics INC | $26.37 | 2025 | |
| Dilon Technologies, INC. | $26.19 | 2025 | Hemoblast Bellows |
| Medtronic, INC. | $17.68 | 2025 | Signia |
| Ferring Pharmaceuticals INC. | $14.45 | 2019 | |
| Daiichi Sankyo INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Bossert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.